Morgan Stanley’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | – | Sell |
-199,065
| Closed | -$4.16M | – | 6692 |
|
2016
Q3 | $4.16M | Buy |
199,065
+190,883
| +2,333% | +$3.99M | ﹤0.01% | 2843 |
|
2016
Q2 | $88K | Sell |
8,182
-63,469
| -89% | -$683K | ﹤0.01% | 5297 |
|
2016
Q1 | $475K | Buy |
71,651
+56,262
| +366% | +$373K | ﹤0.01% | 4483 |
|
2015
Q4 | $279K | Buy |
15,389
+6,507
| +73% | +$118K | ﹤0.01% | 4904 |
|
2015
Q3 | $98K | Buy |
8,882
+5,377
| +153% | +$59.3K | ﹤0.01% | 5431 |
|
2015
Q2 | $50K | Sell |
3,505
-2,721
| -44% | -$38.8K | ﹤0.01% | 5850 |
|
2015
Q1 | $73K | Sell |
6,226
-18,182
| -74% | -$213K | ﹤0.01% | 5658 |
|
2014
Q4 | $406K | Buy |
+24,408
| New | +$406K | ﹤0.01% | 4825 |
|